T RM cells are non-circulating lymphocytes that play a key role in peripheral immunity. T RM cells have been described in both mouse tissues and human tissues such as lung, intestine, brain and skin [1][2][3][4] , show a distinct transcriptional profile and are characterized by CD69 expression and, in some tissues, also CD103 expression [5][6][7] . The T RM cells that reside at peripheral sites orchestrate immune responses against pathogens, but also contribute to autoimmune and allergic disorders 4,[8][9][10] . Furthermore, CD103
T RM cells are non-circulating lymphocytes that play a key role in peripheral immunity. T RM cells have been described in both mouse tissues and human tissues such as lung, intestine, brain and skin [1] [2] [3] [4] , show a distinct transcriptional profile and are characterized by CD69 expression and, in some tissues, also CD103 expression [5] [6] [7] . The T RM cells that reside at peripheral sites orchestrate immune responses against pathogens, but also contribute to autoimmune and allergic disorders 4, [8] [9] [10] . Furthermore, CD103
+ T cells are present in human cancer lesions such as melanoma 11 , ovarian 12 and lung 13, 14 cancers and are enriched in tumor reactivity 15 , and they are therefore thought to play a central role in tumor control.
Intravital imaging studies in mouse models have demonstrated that CD8 + T RM cells in skin tissue actively crawl in between keratinocytes in search of newly infected cells, a property termed tissue patrol 16, 17 . When T RM cells encounter antigen-expressing cells in mouse models, there is a reduction in their motility and dendricity, as revealed by in vivo imaging 16, 18, 19 . Furthermore, encounter of antigen by CD8 + T RM cells induces tissue-wide expression of interferon-γ (IFN-γ)-responsive genes, as demonstrated by transcriptional analyses 20 . While there is a growing appreciation of the relevance of human skin-resident T RM cells in health and disease 4, 21 , the in situ behavior of these cells has not been analyzed. To address this issue, we set out to develop an ex vivo tissue culture system to study the dynamic behavior of T RM cells in fresh skin biopsies. We first validated this system on mouse tissue by comparison of in vivo and ex vivo migration of T RM cells and antigen recognition by ex vivo T RM cells. We subsequently determined how T RM cells in fresh biopsy material could be visualized by staining with fluorescent anti-CD8 nanobodies, without impairing their ability to respond to antigen encounter. We then applied this approach to healthy human skin samples and demonstrate that human CD8
+ skin-resident T RM cells migrate in both the epidermal and dermal compartment. In the epidermal compartment, CD8
+ T RM cells moved along the stratum basale, in close proximity to the basement membrane and below a pool of stationary Langerhans cells. In the papillary dermis, migration of CD8 + T RM cells was observed in regions rich in collagen type I and in collagen type I-poor areas along dermal vessels. This study demonstrates that tissue patrol is a property of human tissue-resident memory CD8
+ T cells and provides a platform to study the real-time behavior of these cells in situ.
Results

Ex vivo migration of murine CD8
+ T RM cells in skin tissue. To study human skin-resident T RM cell behavior in real time, we aimed to set up a skin culture system suitable for live-cell imaging. To this end, we explored an ex vivo culture system previously used to image melanoblast migration 22 to investigate whether T RM cell behavior in such an ex vivo system recapitulates in vivo cell behavior. In this setup, a fresh skin biopsy is mounted between a gas-permeable membrane at the epidermal side and a filter covered by Matrigel and medium on the dermal side (Fig. 1a) . This system ensures gas exchange at the exterior side of the skin, while providing diffusion of nutrients on the interior side.
To examine whether such an ex vivo imaging system can be used to reliably describe the properties of skin-resident T RM cells, we first compared ex vivo T RM cell migration with the well-understood in vivo migratory behavior of skin-resident T RM cells in mice 16, 17 . To this end, mice harboring fluorescently labeled skin-resident T RM cells were generated by injecting C57BL/6 mice with naive CD8 + T cells transgenic for the OT-I T cell antigen receptor (TCR) (specific for the ovalbumin-derived SIINFEKL peptide 
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Before OVA [257] [258] [259] [260] [261] [262] [263] [264] gBT-GFP OT-I-mTmG Post OVA [257] [258] [259] [260] [261] [262] [263] [264] Fig. 1 | Tissue patrol and cognate antigen recognition by ex vivo murine skin-resident T RM cells. a, Illustration of the setup for ex vivo imaging of skin samples. b, Experimental setup to compare the in vivo and ex vivo behavior of skin-resident T RM cells. i.v., intravenous. c, Top, confocal maximum-intensity projections of in vivo OT-I-GFP (green) cells (left; overview and zoomed image) and ex vivo OT-I-GFP cells exposed (middle; overview and zoomed image) or not exposed (right; zoomed image) to air. Bottom, in vivo skin-resident T RM cells (left: median speed, n = 217; right: circularity, n = 342) and ex vivo skin-resident T RM cells exposed to air (left: median speed, n = 185; right: circularity, n = 364) or not exposed to air (left: median speed, n = 33; right: circularity, n = 31). Black dots represent medians of individual tracks of T RM cells (left) or average T RM cell circularity per frame (right), and red lines indicate the median of the cell population. Two-tailed Mann-Whitney U-tests were performed. Data for in vivo and ex vivo with gas exchange are representative of three mice per condition (4-h recording), and data for ex vivo without gas exchange are based on one mouse per condition (1-h recording). d, Confocal maximum-intensity projections (overview and zoomed image) of OT-I-mTmG (red) and gBT-GFP (green) cells before (top left) and after (top right) addition of OVA [257] [258] [259] [260] [261] [262] [263] [264] . Note that, next to red fluorescent T cells, autofluorescent hair fragments are visible in the red channel. Bottom, individual tracks of cells in 1-h (before) and 2-h (after) recordings after normalization of starting positions to the origin. Data are representative of three mice. Scale bars, 50 μm (overview) and 10 μm (zoomed images).
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Nature ImmuNology green fluorescent protein (GFP). The skin of both hind legs was then DNA vaccinated with a plasmid encoding the OVA 257-264 epitope (Fig. 1b) . More than 44 d after induction of a local T cell response, the migration of tissue-resident T cells was analyzed by in vivo confocal microscopy. Directly after in vivo imaging, mice were euthanized and skin tissue was collected and mounted in the ex vivo setup for longitudinal (4-h) confocal-microscopy imaging the next day. In vivo GFP + skin-resident T RM cells displayed the previously described dendritic morphology and constantly migrated within the tissue with a median speed of 0.49 ± 0.29 μm min −1 (Fig. 1c  and Supplementary Video 1) . Imaging of ex vivo skin showed that GFP + skin-resident T RM cells remained present within the epidermis and largely retained their dendritic shape (median circularity of 0.38 ± 0.06 and 0.42 ± 0.03 for in vivo and ex vivo skin-resident T RM cells, respectively; a value of 1.0 represents a fully circular morphology; Fig. 1c , top middle and bottom right). Furthermore, ex vivo skinresident T RM cells also retained their constitutive migratory behavior, with a slightly higher median speed of 0.68 ± 0.70 μm min −1 (Fig. 1c , bottom left, and Supplementary Video 2). Notably, gas exchange in this ex vivo system was crucial to retain the physiological behavior of skin-resident T RM cells, as mounting of murine skin in a setup in which gas exchange was prevented resulted in highly immobile (median speed of 0.08 ± 0.04 μm min ) and circular (median circularity of 0.72 ± 0.01) GFP + skin-resident T RM cells (Fig. 1c , top right and bottom, and Supplementary Video 3). Analysis of migration parameters revealed that ex vivo skin-resident T RM cells displayed a higher motility coefficient than in vivo T RM cells, as indicated by non-overlapping confidence intervals ( Supplementary Fig. 1a) . Nonetheless, persistence time and median turning angles were very similar ( Supplementary Fig. 1a , middle and right). Previous work has demonstrated that intravital imaging of pigmented skin can induce a local immune response owing to death of light-sensitive pigmented skin cells and subsequent recruitment of neutrophils [23] [24] [25] . To study whether the observed T cell behavior could indeed be influenced by death of pigment-positive skin cells, we performed in vivo and ex vivo confocal imaging of T RM cells in the skin of C57BL/6 albino mice. These data demonstrated that the steadystate patrolling behavior of skin-resident T RM cells was independent of the presence of skin pigmentation ( Supplementary Fig. 1b , top and bottom left and middle, and Supplementary Video 4). In addition, the typical T RM cell patrolling behavior observed in confocal imaging was also seen during multiphoton (MP) imaging of GFP + OT-I T RM cells in the skin of C57BL/6 albino mice ( Supplementary  Fig. 1b , top and bottom right, and Supplementary Video 5). In further support of the notion that steady-state migration is an intrinsic property of skin-resident T RM cells, mean speeds remained constant over long periods of confocal and MP imaging in the skin of C57BL/6 black and albino animals ( Supplementary Fig. 1c ).
Having demonstrated that ex vivo skin-resident T RM cells retain their steady-state migratory behavior, we next examined whether these cells could still respond to encounters with cognate antigen. To address this, we injected a mixture of naive OT-I-mTmG CD8 + T cells (positive for the fluorescent dye tdTomato) and naive gBT-GFP CD8 + T cells (positive for GFP) into mice and vaccinated the mice the next day with plasmid encoding the epitope OVA [257] [258] [259] [260] [261] [262] [263] [264] or an epitope derived from herpes simplex virus type 1 glycoprotein B (gB [498] [499] [500] [501] [502] [503] [504] [505] ), to which the T cells are specific. This allowed comparison of the behavior of the two T RM cell populations during ex vivo recall with one of the two antigens. After a rest period of more than 60 d, skin tissue was collected and mounted for ex vivo imaging. Consistent with the data in Fig. 1c , ex vivo OT-I-mTmG and gBT-GFP skinresident T RM cells exhibited a dendritic morphology and continuously crawled within the tissue in steady state (Fig. 1d , left, and Supplementary Fig. 1d, left) . However, upon addition of OVA [257] [258] [259] [260] [261] [262] [263] [264] peptide to the ex vivo medium, OT-I-mTmG cells became more rounded and stalled, with a fourfold reduction in median speed, whereas gBT-GFP cells remained dendritic and motile throughout the recording (Fig. 1d, right, Supplementary Fig. 1d , right, and Supplementary Video 6). Together, these data demonstrate that this ex vivo imaging system recapitulates key aspects of in vivo T RM cell behavior and can hence be used to study skin-resident T RM cells in real time in settings where in vivo imaging is precluded.
Ex vivo labeling with anti-CD8 nanobody allows visualization and tracking of CD8
+ murine skin-resident T RM cells. To visualize the behavior of human CD8
+ skin-resident T RM cells in situ, it was necessary to develop a means to label T RM cells ex vivo. To ensure efficient tissue penetration by fluorescently labeled antibodies in the relatively thick human skin 26 , we generated Alexa Fluor-594 (AF594)-labeled nanobodies (approximately 15 kDa) to either mouse (m) CD8 or human (h) CD8 (hereafter referred to as anti-mCD8 nanobody or anti-hCD8 nanobody, respectively). Subsequently, ex vivo staining of murine skin harboring CD8
+ GFP + skin-resident T RM cells was utilized to validate the use of these reagents. Ex vivo imaging of tissue stained with anti-mCD8 nanobody demonstrated successful labeling of all GFP + cells within the tissue (Fig. 2a, left) , and this signal remained constant over time (Fig. 2a, top right) . In addition, a population of endogenous, non-GFP-transgenic tissueresident CD8
+ cells was detected, as revealed by the presence of single-positive AF594
+ cells. As a control, staining of mouse skin explants with AF594-labeled nanobody reactive with human CD8 did not result in specific staining ( Supplementary Fig. 2a ). Staining of ex vivo mouse skin with anti-mCD8 nanobody did not lead to a substantial change in the morphology of CD8 ; Supplementary  Fig. 2b , top left). Analysis of migration parameters showed a 1.3-fold decrease in median turning angles after nanobody labeling, whereas the motility coefficient and persistence time were very similar to those of unlabeled ex vivo skin-resident T RM cells, as indicated by overlapping confidence intervals ( Supplementary Fig. 2b , top right and bottom). Interestingly, in the majority of the cells, the highest intensity of CD8 staining was observed on the lagging end of migrating skin-resident T RM cells ( Supplementary Fig. 2c ). Because of the monovalency of the labeled nanobodies, this is not expected to be a consequence of labeling-induced receptor clustering and may therefore represent a physiological enrichment at this site.
To understand on which time scales ex vivo culture would affect tissue integrity, we performed histopathology analysis of tissue cultured ex vivo and fixed at different time points after mounting. Nanobody-labeled ex vivo tissue that was imaged for a 4-h time period 1 d after mounting showed only mild degeneration and a mild hypertrophic change in the epidermal squamous cells, and overall skin integrity was maintained ( Supplementary Fig. 2d, top) . Langerhans cells have been described to leave tissues under stress conditions 27 and, as a second measure for tissue stress, we performed staining of Langerhans cells in ex vivo tissue that was fixed at various time points after mounting. This revealed that Langerhans cells remained present ex vivo for up to 72 h of culture (Supplementary Table 1 ). In addition, large numbers of GFP + skin-resident T RM cells were still observed at this time point ( Supplementary Fig. 2d , bottom). To examine whether labeling of T RM cells with anti-mCD8 nanobody would influence their ability to recognize cognate antigen, OVA 257-264 peptide was added to the medium of ex vivo skin harboring GFP + OT-I T RM cells labeled with anti-mCD8 nanobody. After addition of peptide ligand, CD8 + GFP + AF594 + cells showed a 3.4-fold reduction in median speed and became highly circular in less than 30 min, indicating response to antigen encounter (Fig. 2b , top left and bottom, and Supplementary Video 7). As a side note, the previously enriched mCD8 signal at the rear side of patrolling cells appeared to be redistributed over the cell surface upon antigen 
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Nature ImmuNology delivery (Fig. 2b, top right) . While all GFP +
AF594
+ cells stalled after peptide addition, isolated dendritic single-positive AF594
+ cells were observed that continued to migrate after addition of OVA [257] [258] [259] [260] [261] [262] [263] [264] peptide, suggesting that these endogenous cells recognized a distinct epitope. While antigen recognition by T RM cells was not affected by nanobody labeling in these settings, such labeling could potentially affect TCR triggering at lower antigen concentrations. Analysis of activation markers on anti-mCD8 nanobody-labeled mouse T cells cultured in vitro revealed an approximately tenfold reduction in antigen sensitivity ( Supplementary Fig. 2e ). Notably, staining of human T cells with anti-hCD8 nanobody did not measurably influence their antigen sensitivity or recognition of tumor cells that endogenously expressed the cognate antigen ( Supplementary Fig. 3a) .
Collectively, these data demonstrate that ex vivo imaging of CD8 + skin-resident T RM cells is feasible, that these cells retain their physiological tissue patrolling behavior and that such cells can efficiently be labeled with nanobodies in situ.
Migratory behavior of human CD8
+ skin-resident T RM cells. Memory T cells have been observed in healthy human skin, with numbers remaining stable up to 90 years of age 4 . Unlike the T cells present in skin during ongoing infections, T cells present in healthy skin tissue are likely to represent resident memory cells, as revealed by expression of CD45RO, CLA and CD69 (refs. 28, 29 ). To study the behavior of these cells in situ, we mounted punch biopsies of skin material obtained after abdominoplastic or breast-reconstructing surgery for ex vivo imaging and stained these tissues with antihCD8 nanobody. The next day, MP imaging revealed specific staining of CD8 + cells in human skin, as compared to staining with the irrelevant anti-mCD8 (Fig. 3a) . To investigate the localization of CD8
+ cells in human skin samples, tissues were also incubated with the nuclear dye Hoechst to show the distribution of all nucleated cells in these samples. This imaging revealed a subpopulation of CD8
+ cells that was preferentially located in the stratum basale of the epidermis (Fig. 3b, left) . In addition, imaging of collagen type I by second-harmonic generation (SHG) signal showed the presence of sizable numbers of CD8 + cells in the papillary dermis (Fig. 3b , middle and right). To assess whether the observed dermal and epidermal cell populations both reflected resident memory T cells, we analyzed expression of CD69 and CD103 on CD8 + cells isolated from the dermal and epidermal layers, revealing CD69 positivity on nearly all CD8 + cells in both compartments, with a large fraction of cells also expressing CD103 (Fig. 3c ). In addition, this analysis revealed that the in situ labeling of CD8 + T cells identifies the entire CD8 + T cell compartment present in these skin biopsies, as determined by co-staining of single-cell suspensions of in situlabeled cells with conventional antibody to CD8 antibody following digestion ( Supplementary Fig. 3b ).
Long-term MP imaging of human skin stained with anti-hCD8 revealed that CD8
+ T RM cells migrated in the epidermal and dermal compartment, with speeds remaining constant throughout MP imaging sessions (Supplementary Video 8 and Supplementary  Fig. 3c ). Co-staining of ex vivo tissues with anti-hCD8 and the nuclear dye Hoechst revealed that CD8
+ T RM cells in the epidermal compartment migrated in the stratum basale, through a dense environment of keratinocytes (Fig. 3d and Supplementary Video 9) . In contrast to the CD8 + skin-resident T RM cells observed in mouse epidermis, human epidermal CD8 + T RM cells did not only migrate primarily in two dimensions but also followed the three-dimensional (3D) structure of the finger-like dermal projections ( Fig. 3e and Supplementary Video 10). Migration of epidermal T RM cells in close proximity to the basement membrane could likewise be revealed by co-staining with an antibody against collagen type IV, which is one of the major components of the basement membrane 30 ( Fig. 3f and Supplementary Video 10). As only a fraction of human epidermal CD8
+ T RM cells also expresses CD103, we next investigated the location and motility of the CD8 +
CD103
− and CD8 + CD103 + T RM cell subsets. To this end, we co-stained tissue explants with the antihCD8 nanobody and an antibody to hCD103. Real-time imaging of these samples revealed that the CD103 − and CD103 + epidermal CD8 + T RM cell subsets were intermingled and migrated through the tissue, with similar speeds (0.54 ± 0.82 and 0.57 ± 0.64 μm min −1 , respectively). In all double-positive epidermal T cells, the CD103 antibody complex was enriched at the lagging end of migrating CD8 + T RM cells ( Fig. 3g and Supplementary Video 11). This location may potentially be explained by labeling-induced receptor clustering, and future studies using different labeling strategies may test this. Ex vivo staining of tissue with anti-hCD1a also allowed visualization of Langerhans cells. MP imaging showed that Langerhans cells were located above CD8
+ skin-resident T RM cells in the upper layers of the epidermis pointing their dendritic protrusions upward ( The majority of human CD8 + skin-resident T RM cells were found to be located in the dermal compartment ( Fig. 3b) , providing the opportunity to also examine the migratory behavior of human CD8 + T RM cells at a second tissue site. To this end, real-time MP imaging sessions (3.5-4 h) of skin tissue from four individuals were performed. Human CD8 + skin-resident T RM cells migrated through the dermis with median speeds around 0.40 ± 1.09 μm min −1 (Fig. 4a, 
left). As compared with murine epidermal CD8
+ skin-resident T RM cells, human dermal CD8 + T cells showed a larger heterogeneity in speed at the single-cell level. Persistence times and motility coefficients were similar for murine CD8 + skin-resident T RM cells 
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Nature ImmuNology and human dermal T cells when these were estimated from shortterm observation windows (Fig. 4a, middle and right) . However, in contrast to murine CD8 + skin-resident T RM cells, long-term migration of human dermal CD8 + T cells could not be described as a persistent random walk ( Supplementary Fig. 3d ). Migration of human dermal CD8
+ skin-resident T RM cells was observed in both regions dense in collagen type I and regions with little collagen type I (Fig. 4b , top image), with a fraction of CD8 + T cells in areas with little collagen type I migrating along the perimeter of these structures (Fig. 4b , middle and bottom images, and Supplementary Video 13). Analysis of skin biopsies co-stained with anti-hCD8 nanobody and an antibody to collagen type IV to identify basement membranes Technical RepoRT Nature ImmuNology revealed that regions with little collagen type I were frequently filled with dermal vessels such as blood capillaries (Fig. 4c, top) , and realtime imaging of these explants showed examples of dermal CD8 + T RM cells migrating along the lining of these vessels (Fig. 4c, bottom, and Supplementary Video 14) .
To examine whether local presence of collagen type I affects T RM cell migration, we compared the speed steps of T RM cells at sites with high and low levels of collagen. While the median speeds for cells in areas rich in collagen type I were highly similar to speeds in areas with little collagen type I, fast speed steps were observed significantly more often in areas with little collagen type I, suggesting that collagen type I forms a barrier for dermal T RM cell migration ( Supplementary Fig. 3e ).
Finally, in three out of five explants analyzed, cases of CD8 
Nature ImmuNology were observed (Fig. 4d and Supplementary Video 15) . While large datasets are required to understand the magnitude of this process, these data suggest that T RM cells at the two sites might not correspond to two fully separate compartments.
Collectively, these data demonstrate that human CD8 + skin-resident T RM cells patrol both the epidermal and dermal compartment and, using labeling of three cell-surface markers and one extracellular protein, show that the ex vivo imaging system that we have developed provides a versatile tool to study the behavior of skinresident immune cell populations in real time.
Discussion
To our knowledge, this is the first longitudinal analysis of the behavior of resident memory T cells in human tissue. To allow this, we established an ex vivo imaging system for the in situ labeling and real-time tracking of CD8 + T RM cells in human skin. Using this approach, we demonstrate that human CD8 + cells actively migrate in both the epidermal and dermal layers of the skin, with median speeds in the same range as those of murine CD8
+ skin-resident T RM cells. These CD8
+ cells reflect tissue-resident memory T cells, as all CD8 + cells isolated from both skin compartments express CD69, the principal defining feature of T RM cells 6, 29 . These data establish that tissue patrol is a property of human CD8
+ skin-resident T RM cells and fit with the model that relatively rare CD8
+ T RM cells can act as local sentinels to provide a rapid and tissue-wide anti-pathogen response 20, 31 . The observation of T RM cell patrol in both the dermis and epidermis, two sites with a different tissue architecture, combined with the fact that tissue patrol has been observed for murine T RM cells in multiple organs 16, 18, 32 , makes it reasonable to postulate that a continuous migratory behavior forms a shared property of all human CD8
+ T RM cell populations. In the epidermal compartment, human CD8
+ T RM cells migrate in the stratum basale in a dense environment of keratinocytes. The adhesive interactions between epithelial cells and T lymphocytes includes the binding of E-cadherin to the α E -(CD103) β 7 -integrin that is present on many tissue-resident T cells 33 . With the caveat that antibody labeling may potentially influence this interaction, in the current dataset we did not find any evidence for a difference in motility between single-positive CD8
+ T RM cells and those that also expressed CD103.
Consistent with previous data 34 , the majority of CD8 + T cells in healthy human skin were observed in the dermal compartment. These cells show a distinct migratory behavior when compared with murine CD8 + skin-resident T RM cells, with a larger heterogeneity in speed. One explanation for this heterogeneity is that the dermis comprises different structures that may form barriers to T RM cell migration. Further evidence for a model in which local structure may influence parameters of T RM cells migration comes from the observation that T RM cells in dermal areas with low density of collagen type I show a higher frequency of fast steps than those in high-density areas. In line with this, the former areas have been described to contain collagen type III, and connective tissues enriched for this collagen are described to be more flexible than tissues dense in collagen type I (refs. 35,36 ). Within areas with low collagen type I density, examples of T RM cells migrating along the lining of blood capillaries were observed. Given the strategic positioning of these T RM cells, it may be postulated that they are located at these sites to patrol epidermal supply routes. Contrary to the notion of epidermal CD8 + T RM cells as a fully isolated cell compartment that has emerged from mouse model studies, we also encountered examples of human CD8
+ skin-resident T RM cells located at the dermal-epidermal junction migrating in and out of the dermis. While the basement membrane forms a tight boundary between these two compartments, the potential for immune cells to cross this barrier through small pores has previously been suggested by electron microscopy analyses 37 .
From a technological perspective, the successful ex vivo staining not only with anti-CD8 nanobodies but also with full-size antiCD1a, anti-collagen type IV and anti-CD103 indicates that the current system may be utilized to study a wide variety of skin molecules and cell types of interest in real time. As in all imaging experiments that use exogenous labels, and as illustrated by the reduction in antigen sensitivity of mouse T cells but not human T cells upon staining with anti-CD8 nanobodies, it will be important to understand whether labeling influences cell behavior. In future studies in healthy human skin, it will be interesting to investigate whether the CD4 +
CD103
− memory T cells that are present at high density in the dermis 28,29 show a similar patrolling behavior as CD8 + T RM cells and whether these cells colocalize with either CD8 + T RM cells or defined antigen-presenting cell populations. Finally, although the current study focuses on the behavior of tissue-resident T cells in healthy tissue, this ex vivo technology should also provide a tool to study T cell behavior in the effector and memory phases of T RM cellmediated skin conditions 4, 21 .
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Methods
Mice. C57BL/6J-Ly5.1 (referred to in the text as C57BL/6 mice), C57BL/6J OT-I, C57BL/6J mTmG and C57BL/6J UCB-GFP transgenic mice were obtained from Jackson Laboratories, and the C57BL/6JRjAlbino strain was obtained from Janvier labs. C57BL/6J gBT I.1 TCR-transgenic mice were a kind gift from F. Carbone (Doherty Institute). All animals were maintained and crossed in the animal department of the Netherlands Cancer Institute (NKI). All animal experiments were approved by the Animal Welfare Committee of the NKI, in accordance with national guidelines.
Adoptive transfer and DNA vaccination. CD8 + T cells were obtained from singlecell suspensions of spleens from OT-I-GFP, gBT-GFP or OT-I-mTmG mice using the mouse CD8 + T lymphocyte enrichment kit (BD Biosciences). Mice received a total of 2 × 10 5 CD8 + cells intravenously in the tail vein. DNA vaccination was performed on depilated hind legs of anesthetized mice by application of plasmid DNA encoding TTFC-OVA 257-264 (SIINFEKL) or a mix of TTFC-OVA [257] [258] [259] [260] [261] [262] [263] [264] (SIINFEKL) and TTFC-gB 498-505 (SSIEFARL) (three rounds of vaccination, using 60 μg of DNA per vaccination 38, 39 ), by means of a sterile disposable nine-needle bar mounted on a rotary tattoo device (MT.DERM).
Generation of fluorescently labeled nanobodies. Escherichia coli cells were transformed with the expression vector pHEN6 encoding either the anti-mouse CD8 nanobody 118 or the anti-human CD8 nanobody 218, followed by an LPETGG-6×His sequence. Bacteria were grown to optical density of 0.6-0.8 at 37 °C, and protein production was induced with 1 mM isopropyl-β-dthiogalactoside overnight at 30 °C. Cells were collected, resuspended in 1× TES buffer (200 mM Tris pH 8, 0.65 mM EDTA and 0.5 M sucrose) and incubated at 4 °C for 1 h. Subsequently, cells were exposed to osmotic shock by 1:4 dilution in 0.25× TES buffer overnight at 4 °C and the periplasmic fraction was isolated by centrifugation and loaded onto Ni-NTA beads (Qiagen) in 50 mM Tris pH 8, 150 mM NaCl and 10 mM imidazole. Protein was eluted in 50 mM Tris pH 8, 150 mM NaCl and 500 mM imidazole loaded onto a Biosep 3000 Phenomenex gel filtration column running in PBS, and the appropriate fractions were collected. Purity of recombinant nanobody was assessed by SDS-PAGE analysis and material was concentrated using an Amicon filtration unit with a 10-kDa molecular-weight cutoff (Millipore) and stored at −80 °C. To generate the fluorescent label, 1 mg of AF594 maleimide dye (Thermo Fisher Scientific) was ligated to 200 μM GGGC peptide in the presence of 10 mM NaHCO 3 and purified on a C5 column (Waters). To covalently link the fluorescent label to the nanobody, sortase reactions were performed. To this end, purified GGGC-AF594 (80 μM) was incubated with purified nanobody-LPETGG-6×His (5 μM) and penta-mutant (5 M) or heptamutant (7 M) sortase (0.8 μM) for 2 h at 4 °C in 50 mM Tris pH 8 and 150 mM NaCl, and in the case of the penta-mutant, 10 mM CaCl 2 was added (sortase was produced in house according to a previously described protocol using sonification instead of French press 40 ). Sortase and unreacted nanobody were removed by adsorption onto Ni-NTA agarose beads (Qiagen). Subsequently, the unbound fraction was added on top of a filter with a molecular-weight cutoff of 100 kDa to remove Ni-NTA agarose beads, flowthrough was concentrated and unconjugated GGGC-AF594 was removed using an Amicon filtering unit with a 10-kDa molecular-weight cutoff (Millipore) by exchanging the protein solution three times with PBS. The material was further purified using a zeba spin column (Thermo Fisher Scientific). Resulting anti-mouse and anti-human CD8-AF594 nanobody conjugates were stored in aliquots at −20 °C. Protein concentrations were determined using NanoDrop, and individual batches of labeled nanobody were titrated for optimal usage (final concentrations ranging from 5 to 10 μg ml −1 ).
Functional in vitro analysis of murine T cells labeled with anti-mCD8 nanobodies.
For functional analysis of murine T cells stained with anti-mCD8 nanobody in vitro, a spleen of a C57BL/6J OT-I mouse was mashed and resuspended in RPMI (Thermo Fisher Scientific), fetal calf serum (8% final; SigmaAldrich), penicillin streptomycin (100 U ml
) and l-glutamine, supplemented with 50 μM β-mercaptoethanol, non-essential amino acids, 1 mM sodium pyruvate and 10 mM HEPES (all Thermo Fisher Scientific), and plated in 96-well tissue-treated plates. Cells were then labeled with anti-mCD8-AF594 or anti-hCD8-AF594 at the same concentration as used for the peptide stimulation experiments in ex vivo murine tissue material (5 μg ml −1 final) for 4 h, washed twice and subsequently stimulated overnight with indicated amounts of OVA 257-264 peptide. After 14-18 h, cells were washed twice and stained with anti-mCD8-beta-PeCy7 (eBioH35-17.2, eBioscience), anti-mouse-TCR V beta 5.1/5.2-APC (MR9-4, Thermo Fisher Scientific), anti-mCD25-BV650 (PC61, BioLegend), anti-mCD69-APC-Cy7 (H1.2F3, BioLegend) and 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI) (Sigma-Aldrich) to exclude dead cells and samples were measured on an LSR II SORP (BD Biosciences). Cells were analyzed according to the gating strategy shown in Supplementary Fig. 4a .
Functional in vitro analysis of human T cells labeled with anti-hCD8
nanobodies. For functional analysis of anti-hCD8 nanobody stained human T cells in vitro, we used T cells transduced with two TCRs that recognize a CDK4-derived neoantigen with different affinities (ref. 41 and data not shown). In brief, T cells were plated in 96-well tissue-treated plates in RPMI (Thermo Fisher Scientific), human serum (8% final; Sigma-Aldrich) and a penicillin-streptomycin mixture (100 U ml
) (Thermo Fisher Scientific) and labeled with anti-mCD8 or antihCD8 at the same concentration as used for ex vivo imaging of human tissue material (5 μg ml −1 final) for 4 h. Cells were then washed twice and co-cultured overnight with JY cells (American Type Culture Collection (ATCC); loaded with the indicated concentrations of CDK4 mut peptide (ALDPHSGHFV 41 )) or with the CDK4 wt cell line MM90904 (a kind gift from M. Donia (Herlev Hospital)) or the CDK4 mut cell line NKIRTIL006 (ref. 42 ) at a 1:1 ratio. After incubation for 14-18 h, cells were washed twice and stained with anti-hCD8a-PerCP-Cy5.5 (SK1, BioLegend), anti-mouse-TCR beta-AF488 (H57-597, BioLegend) to detect the TCR-modified cells 41 , anti-hCD137-BV421 (4B4-1, BioLegend) and near-infrared dye (Thermo Fisher Scientific) to exclude dead cells, and samples were measured on an LSR II SORP (BD Biosciences). Cells were analyzed according to the gating strategy shown in Supplementary Fig. 4b .
Ex vivo preparation, labeling and peptide stimulation of mouse tissue. Skin tissue was obtained with forceps from depilated hind legs of mice that had been euthanized and was cleared of connective tissue and fat. Skin pieces were mounted in ex vivo Lumox 35-mm dishes (for adherent cells, Sarstedt), with the epidermis facing downward to the gas-permeable bottom. For analysis in the absence of air, a 35-mm glass-bottom WillCo dish was utilized (WillCo wells). A gas-permeable film (8 μm pores, 25-mm diameter; Sigma-Aldrich) was placed on top of the dermal side of the skin, followed by a layer of LDEV-free reducedgrowth-factor basement membrane matrix Matrigel (Geltrex, Invitrogen) and culture medium consisting of Opti-MEM (Thermo Fisher Scientific), fetal calf serum (8% final; Sigma-Aldrich), penicillin-streptomycin mixture (100 U ml −1 ) and l-glutamine (both Thermo Fisher Scientific). When imaging ex vivo tissue directly after collection and mounting, skin-resident T RM cells exhibited higher circularity and were relatively immobile, but cells regained motility and dendricity overnight (data not shown). Histopathology analysis showed that skin conditions deteriorate over time, with mild alterations in the first 24 h but signs of severe skin degeneration apparent at 72 h ( Supplementary Fig. 2d, top) . For these reasons, all ex vivo experiments were performed after an overnight recovery period, but no later than 24 h after mounting. For ex vivo labeling, skin samples were incubated with anti-mCD8 or anti-hCD8 overnight at 37 °C and 5% CO 2 and washed twice before imaging. For peptide stimulations, OVA 257-264 peptide was added to the ex vivo culture medium (80 nM final concentration) and imaging was performed immediately after.
In vivo and ex vivo mouse skin imaging. Isoflurane-anesthetized mice were placed in a custom-built chamber, with the depilated skin of the hind legs placed against a coverslip at the bottom side of the chamber. In case of imaging of ex vivo skin tissue, the dish with mounted tissue was placed in an inlay, with the epidermal side facing downward. The lid of the dish was removed and the dish was covered with gas-permeable CultFoil to prevent evaporation (Pecon), topped by a custombuilt cover connected to a CO 2 flow. Images were acquired using an inverted Leica TCS SP5 confocal scanning microscope equipped with diode and argon lasers and enclosed in a custom-built environmental chamber that was maintained at 37 °C using heated air. Images were acquired using a 20×/0.7-NA dry objective. GFP was excited at a wavelength of 488 nm and detected between 498 and 550 nm. To visualize AF594 signal, the sample was excited at 594 nm and signal was detected between 604 and 700 nm. For imaging of mTmG + cells, a wavelength of 561 nm was used to excite tissue and signal was detected between 571 and 700 nm. 3D z stacks (typical size 388 μm × 388 μm × 23 μm; typical voxel size 0.8 μm × 0.8 μm × 1.0 μm) were captured every 2 min for a period of up to 4 h.
Histopathology and immunohistochemistry.
For histopathology analyses, 2-μm-thick formalin-fixed, paraffin-embedded full-thickness murine tissue slides were stained with hematoxylin and eosin. Immunohistochemical analysis was performed on 4-μm-thick serially cut slides stained with anti-GFP (ab6556, Abcam) or anti-Langerin (CD207, eBioRMUL.2, eBioscience). Antibody staining was visualized with 3,3′-diaminobenzidine (Sigma). Slides were evaluated and scored by an animal pathologist blinded to experimental conditions. Ex vivo imaging of human skin. Punch biopsies (5 mm) were taken from resected normal human skin tissue directly after abdominoplastic or breast-reconstructing surgery, obtained without informed consent in accordance with national ethical guidelines. Skin was cleared of fat and connective tissue and mounted as described in Fig. 1a . For ex vivo labeling, samples were incubated with anti-mCD8 or antihCD8, Hoechst 33342 (5-10 μg ml −1 final concentration; Thermo Fisher Scientific), anti-human-CD1a-AF488 (4-8 μg ml −1 final concentration; HI149, BioLegend), anti-human-collagen type IV-AF488 (6.25-12.5 μg ml −1 final concentration; 1042, Thermo Fisher Scientific) or anti-human-CD103-AF488 (concentrated on an Amicon spin column with a 100-kDa cutoff (Millipore) and resuspended in PBS to remove sodium azide; used at a 5-10 μg ml −1 final concentration; Ber-ACT8, BioLegend) overnight at 37 °C and 5% CO 2 , as indicated. Antibodies were titrated per individual, to accommodate variability in skin thickness and permeability. For subsequent MP imaging, ex vivo culture dishes were washed twice and topped
Technical RepoRT
Nature ImmuNology with ex vivo culture medium (described above), enclosed with parafilm and placed under an upright Leica SP8 system equipped with a Spectraphysics Insight Deepsee laser. Images were acquired with a 25×/0.95-NA water-immersion objective (Leica Fluotar VISIR), two NDD HyD detectors and an 8,000-Hz resonant scanner in a custom-built environmental chamber that was maintained at 37 °C using heated air supplemented with 5% CO 2 . For detection of AF594 and AF488, the wavelength was tuned to 800 nm and detected with 615/30 and 525/50 band-pass filters (BPFs), respectively. For detection of the SHG signal, the wavelength was tuned to 1,050 nm and detected with a 525/50 BPF. For detection of Hoechst signal, laser was tuned to 800 nm and detected with a 450/65 BPF. 3D stacks (typical size 591 μm × 591 μm × 130 μm; typical voxel size 0.6 μm × 0.6 μm × 1.0 μm) were captured every 3 min for periods of up to 4 h. For identification of structures positive for basement membrane, such as blood capillaries, anti-collagen type IV staining was scored by two independent pathologists. Provided that the human skin sample was imaged within the predetermined 24-h time window and stained with optimally titrated antibodies, motile CD8
+ T cells could be observed in all samples (n = 18 donors), with cells having a large heterogeneity in cell speed. Note that Hoechst dye must be titrated carefully, as excess amounts reduce CD8 + T cell mobility.
Flow cytometry of human skin samples. For analysis of human skin-resident T RM cells by flow cytometry, fresh full-thickness human skin was kept at 4 °C overnight and 0.4-mm thick sheets were prepared with a dermatome the next morning. Subsequently, the epidermis and dermis were separated after a 2-h incubation with dispase (0.2% wt/vol; Sigma-Aldrich) at 37 °C. Epidermis was further digested using trypsin-EDTA (0.05% final; Thermo Fisher Scientific) for 30 min at 37 °C. Singlecell suspensions of the dermis were obtained by incubation with collagenase type I (0.2% final; Invitrogen) and DNase (30 IU ml
; Sigma) under continuous agitation for 2 h at 37 °C. Single-cell suspensions were cultured overnight in low-dose human recombinant IL-2 (30 IU ml
; Novartis) in RPMI (Thermo Fisher Scientific), fetal calf serum (8% final, Sigma-Aldrich), penicillin-streptomycin mixture (100 U ml
) and l-glutamine (both Thermo Fisher Scientific). Cells were subsequently stained with anti-CD8-BB700 (HIT8a, BD Biosciences), anti-CD69-BV421 (FN50, BioLegend) and anti-CD103-PE (Ber-ACT8, BioLegend). Single-cell suspensions of MP-imaged biopsies were counterstained with anti-CD8-PerCP-Cy5.5 (SK1, BioLegend). Dead cells were excluded using near-infrared dye (Thermo Fisher Scientific). Flow cytometry data were acquired using an LSR II SORP (BD Biosciences). Cells were analyzed according to the gating strategy shown in Supplementary Fig. 4c .
Data analysis.
For image analysis, raw data (murine recordings) or Gaussianfiltered data (automatically determined radius; human recordings) were processed with Imaris (Bitplane). To improve visualization of objects located deep in human skin tissues, an attenuation correction was performed, as determined by a correction factor measured on the AF594 channel intensity in 'slice' viewer. To track fluorescent objects, the Imaris Spots module was used to calculate cell coordinates (mean positions) over time. In the subsequent analyses, which were performed in R (https://www.r-project.org/) and in Perl (https://www.perl. org/), cellular mean positions within a 10-μm distance from the lateral image borders were discarded, as these would slightly bias the results (for example, underestimate the speeds) 43 . Tissue drift was corrected by tracking the mean positions of stationary reference points resulting from autofluorescence and/ or second-harmonics signal and by using the shift in these stationary points to correct the cellular movement. For the analysis to determine the effect of previous imaging time on speed, two-dimensional speeds were calculated on the basis of cell coordinates in a stepwise manner 43 ; that is, migration steps were treated independently of the track from which they originated. The large majority of recordings (>91.3%) showed a T RM cell migration speed that was approximately stable over time; in one case a gradual decrease and in one case a decay in speed at later time points were observed, but these are probably indicative of a general decrease in cell viability in these samples. For this reason, the data from the time frames with a decay in speed were not utilized. To determine migration on a per-cell basis, two-dimensional speeds were calculated from cell coordinates and medians were calculated for each cell. Turning angles between consecutive movement steps were determined by calculating the angle between the vectors representing these steps and medians were calculated for each cell. For both speeds and turning angles on a per-cell basis only tracks with a minimum of five time points were incorporated. Motility coefficients and persistence times were estimated from mean square displacement plots by fitting Fürth's equation 44 for a persistent random walk, that is,
t t P 2 t , where x 2 is the mean square displacement, n is the dimension of the space, M is the motility coefficient, P t is the persistence time and t is the time elapsed since the start of the trajectory. To quantify the average motility behavior across multiple replicates, a 95% confidence interval was calculated on the basis of bootstrapping from actually observed tracks. For this purpose, artificial instances of replicates were generated by first randomly selecting the same number of tracks from a replicate as in the original replicates (with replacement). Subsequently, a weighted average of these tracks was determined, where the weight was based on the number of intervals occurring within each track. For instance, a track that is observed during 10 subsequent time points contributes 4 times to the observation of a time window of length 5, whereas a track observed during 14 subsequent time points contributes 8 times to this time window; thus, the latter obtains a twofold higher weight in the calculation. The 95% confidence interval for M and P t was determined on the basis of 1,000 instances of such artificially generated replicates. To compare the motility parameters of human versus mouse skin-resident T RM cells, we fitted the data on the first 15 min of the mean square displacement because the human migration data do not conform to the pattern expected for persistent random walkers over long time intervals.
To investigate the relationship between local collagen type I (SHG) signal and dermal CD8 + T RM cell speed, a 3D surface was created on SHG signal (Gaussian smoothing factor, filter width: 0.75 μm) and segmented into a binary signal (Imaris). Step-based speeds were then calculated for the tracks on the basis of their 3D distance to the nearest SHG + voxel; that is, steps starting at a maximum distance of 1 μm from an SHG voxel were classified as being inside collagen type I (SHG + ) and those at a larger distance as being outside collagen type I (SHG − ). Distributions of artificial replicates were generated by randomly sampling an equal number of observations from the SHG + and SHG − steps, as in the original data (with replacement). The 95% confidence interval for the 0.75 quantile was determined on the basis of 1,000 replicate instances.
For visual clarity of the MP maximal-intensity projections in Fig. 3a and Supplementary Videos 8 and 11, the autofluorescent layer at the top of the epidermal side (observed in all samples in all channels) was removed using the 'surfaces' and 'mask' functions in Imaris. To reduce noise in the overview images in Fig. 3a ,g and Supplementary Video 11, a median filter was applied (onepixel radius). Bleed-through of AF488 signal into the SHG and AF594 channel was corrected in Supplementary Videos 14 (section I) and 15 (section III) by a spillover factor determined by intensity measurements in the Imaris 'slice viewer' . For quantification of human CD8 + T cells in the epidermal and dermal skin compartments, the position of AF594
+ objects relative to collagen type I (SHG) was determined in the 'section viewer' and 'slice viewer' , where cells located above the SHG signal were categorized as epidermal, whereas cells located below the start of the SHG signal were allocated to the dermal compartment. Human dermal CD8 + skin-resident T RM cells were defined as tracks located below the start of the SHG signal for the entire duration of the recording.
Circularity of GFP + murine skin-resident T RM cells was assessed using a macro in Fiji 45 that was developed in house. In short, recordings were first filtered by a 3D median filter (0.5-pixel radius) to reduce noise, after which maximum-intensity projections were created. Cells were then segmented using automatic thresholding (RenyiEntropy) for each frame. Circularity is measured as 4πA/P 2 (where A is the projected (two-dimensional) cell area and P is the one-dimensional cell perimeter).
For flow cytometry experiments, data were analyzed using FlowJo (Tree Star). Graphs were made in GraphPad Prism (GraphPad Software) or in R.
Statistics. Statistical analyses were performed in Prism (GraphPad). Two-tailed MannWhitney tests were used, with results regarded as statistically significant at P < 0.05.
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Data analysis
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Field-collected samples
The study did not involve samples collected from the field.
Ethics oversight
All animals were maintained and bred in the animal department of The Netherlands Cancer Institute (NKI). All animal experiments were approved by the Animal Welfare Committee (NKI, the Netherlands), in accordance with national guidelines.
Note that full information on the approval of the study protocol must also be provided in the manuscript.
Human research participants
Policy information about studies involving human research participants
Population characteristics
Human skin samples in this study were collected during abdominoplastic and breast reconstructing surgery.
Recruitment
No patients were specifically recruited for this study. Human samples were taken from skin material obtained during planned surgeries.
Ethics oversight
In accordance with national guidelines, informed consent is not required for use of this material. Patient characteristics cannot be coupled to these samples.
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Methodology
Sample preparation 
Software
To collect data BD FACSDIVA was used, for analysis FlowJo was used.
Cell population abundance No sorts were performed in this study.
Gating strategy
In all samples, lymphocyte population was selected by FSC-A/SSC-A gating. Doublets were then gated out by FSC-A/FSC-H and additional gating on SSC-A/SSC-H. Dead cells were excluded by near-IR dye or DAPI. For in vitro stimulation experiments, murine T cells were then gated on CD8b+ Vb5+, and plots depicting CD25 versus CD69 were generated ( Supplementary Fig. 2e ). Human T cells were gated on CD8+ mTCRb+ CD137+ cells ( Supplementary Fig. 3a ). For human skin samples, plots were then generated depicting anti-hCD8-nanobody versus anti-hCD8-antibody positive cells ( Supplementary Fig. 3b) , or cells were then gated on CD8 positivity, and plots depicting CD69 versus CD103 were generated (Fig. 3c ). Gates were placed based on the position of the negative population.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
